> TRIPS and public health

> WHO-WIPO-WTO cooperation on intellectual property and public health

  • The Workshop will be held at the WTO, Centre William Rappard, rue de Lausanne 154, Geneva, in Room E, on 27 October 2015 from 14h00 to 18h00;
  • Online registration is mandatory and is available here until 23 October 2015.

The workshop will provide participants with practical insights into how the main substantive patentability criteria are applied in practice at country level and how different interpretations can impact on public health. It is expected to support participants to engage in a policy debate that is characterized by its highly technical nature and assist them to appropriately frame and assess national patent systems and practices.

The three collaborating agencies will provide a brief overview of the legal framework at multilateral, regional and national level, and illustrate the potential impact of the definition of patentability criteria on public health by looking at specific examples. This will be followed by an interactive session led by a practitioner who will present and discuss a number of practical cases. The final discussion will open the floor to a broader discussion on the issues dealt with before and also to matters of public interest and concerns with respect to the design and application of patentability criteria at country level and potential repercussions on public health.

The Workshop will be held in English only; no interpretation will be available. Subject to availability of space, participation is open to all interested individuals and organizations. Registered participants without UN or WTO accreditation need to bring official identification.

The Workshop will take place back to back with the WHO-WIPO-WTO Symposium on "Public Health, Intellectual Property, and TRIPS at 20: Innovation and Access to Medicines; Learning from the Past, Illuminating the Future" that will be held at the WTO on 28 October 2015.



14h00 — 14h10

Welcome and introduction

14h10 — 15h15

Patentability criteria and public health

    Patentability criteria pursuant to the TRIPS Agreement
    Roger Kampf, Counsellor, Intellectual Property Division, WTO

    Patentability criteria and patent grant procedures at country level
    Tomoko Miyamoto, Head, Patent Law Section, WIPO

    Impact of patentability criteria on public health
    Peter Beyer, Senior Advisor, Department of Essential Medicines & Health Products, WHO     


15h15 — 17h00

Application of patentability criteria to concrete pharmaceutical patent cases

    Markus Engelhard, Boehmert & Boehmert, Munich/Germany

17h00 — 18h00

Open discussion on patentability criteria and domestic needs

    Moderator: Antony Taubman, Director, Intellectual Property Division, WTO


RSS news feeds

> Problems viewing this page?
Please contact webmaster@wto.org giving details of the operating system and web browser you are using.